Veterinary Medicines: Northern Ireland
Debate between Robin Swann and Emma Hardy(2 weeks, 3 days ago)
Westminster HallRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
Emma Hardy
I thank the hon. and learned Gentleman; of course, I reject the phrase “EU masters”. These schemes are really important to make sure that the vets or those who require the medicine have the medicine that they need in Northern Ireland.
I want to take this opportunity to make a few further remarks about our assessment on discontinuations. In June, the Government said that “fewer than 20 products” are expected to be discontinued where there was risk of “significant adverse impacts” if not addressed through our schemes. I am pleased to announce that further analysis has reduced that figure to six. Following extensive engagement and detailed analysis, we are now satisfied that none of these discontinuations would lead to a health situation or other significant adverse impacts.
In some cases, the products will no longer be discontinued; in others, there are sufficient alternatives available in Northern Ireland or from the EU. However, we will of course continue to monitor the list and any new discontinuations, and we welcome stakeholder feedback. On divergence, the veterinary medicines regulations for Great Britain were updated in 2024 to reflect the comparable EU regulations 2019/6 and 2019/4, thereby basically bringing Great Britain and Northern Ireland into closer alignment.
These are the regulations that will apply in Northern Ireland from the end of the grace period. Divergence between Great Britain and Northern Ireland veterinary medicine regulation is minimal, and is something that the Veterinary Medicines Directorate monitors closely in considering where alignment may be beneficial.
I will now address some of the other concerns raised. We have heard that stakeholders are concerned about insufficient pack sizes being available and about that leading to cost increases and issues with dispensing veterinary medicines. However, based on our extensive engagement, we have no evidence that pack size changes are a systematic issue. Where pack size changes occur, we expect the most popular sizes to remain, but of course, if the situation changes or if new evidence comes to light, we will look to use the schemes we have in place.
More broadly on costs, we have had positive reassurance from a number of pharmaceutical companies that they will not increase prices, but we will closely monitor the situation into 2026.
Robin Swann
With regard to market surveillance to look at costs, what powers do the Government have, should a pharmaceutical supplier decide to increase costs? That would be interfering with the commercial market, and I do not see where the Government have the powers to do what they say they want to do, or may do, in that instance.
Emma Hardy
The hon. Gentleman raises an important point. We would of course look at whatever powers we have at our disposal, but as a Government we do not want to see costs unfairly increased for Northern Ireland customers. That is the important principle that we are trying to address by doing this. We hope that that will not be the case, but if it is, we would need to work closely and carefully with all stakeholders in Northern Ireland, and we would of course follow up with meetings with representatives from Northern Ireland about that.
We are not complacent. The Government’s position is based on our assessment of the best possible evidence available, and we take stakeholder concern extremely seriously. As I mentioned at the beginning, Baroness Hayman was in Northern Ireland just last week for a couple of days, meeting with people about this very issue. I know that it is something she cares about and sees as incredibly important.
Our view is based on what we can see. The transition to new arrangements at the end of the year will be manageable, but if there are unexpected problems, we have our two schemes to manage that. I also note that there will not be a cliff edge on supply at the end of the year. All medicines supplied to Northern Ireland before the end of this year will remain available, and some of those products have long shelf lives. We have advised businesses to take prudent action, but that is just in case. We have put in many different mitigations to try and resolve this issue. We will continue to monitor the situation closely, and we will respond rapidly if issues arise. As I mentioned at the beginning of my speech, we want to continue and maintain open dialogue with all representatives.
Robin Swann
The Minister has been gracious in taking interventions. One issue that she has not touched on yet is pet owners with a prescription who buy medication online from GB suppliers. What reassurance can she give us there? I have heard everything that she has said to date, but I have not heard her address that issue.
Emma Hardy
Through our engagement, we are aware of multiple companies that are either being established in Northern Ireland or planning to set up as online retailers there. That is expected to ensure that medicines will remain available through online channels. The Government appreciate that access to online retailers for pet owners to obtain veterinary medicines for their pets is of great importance, so this is something we are monitoring closely. Of course, it would be a positive outcome if those companies were setting up as online retailers in Northern Ireland. As a pet owner myself, I recognise how important it is for pet owners to be able to get the medication their beloved pets need.
We will continue to monitor the situation closely and will respond rapidly. We welcome feedback from stakeholders on specific issues and will continue to work with industry as we have done.
Oral Answers to Questions
Debate between Robin Swann and Emma Hardy(7 months, 1 week ago)
Commons ChamberRead Full debate Read Hansard Text Read Debate Ministerial Extracts
Emma Hardy
I pay tribute to the hon. Member’s ability to weave a question for the Department for Energy Security and Net Zero into a question on flooding. He will have heard from the Nature Minister how important peatlands are and how essential they are for this country and heard our commitment to protecting them.
Robin Swann (South Antrim) (UUP)